References
- Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375–87.
- Noizat-Pirenne F, Tournamille C. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011;18:527–35.
- Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood 2018;132: 1198–207.
- Chou ST, Flanagan JM, Vege S, et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv 2017;1:1414–22
- Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.
- Gaspardi AC, Sippert EA, De Macedo MD, Pellegrino J Jr, Costa FF, Castilho L. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors. Blood Transfus 2016;14:449–54.
- Sippert E, Fujita CR, Machado D, et al. Variant RH alleles and Rh immunisation in patients with sickle cell disease. Blood Transfus 2015;13:72–7.
- Keller MA, Mansfield P, Maurer J, et al. Identifying compatible blood for RH alloimmunized patients: an international case. 29th Regional Congress of ISBT (Abstract P-036). Vox Sang 2019;114:85.
- Floch A, Tournamille C, Chami B, Pirenne F. Genotyping in sickle cell disease patients: the French strategy. Transfus Med Hemother 2018;45:264–70.
- Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008;112:2546–53.
- Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528–37.
- Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype. Haematologica 2014;99:e115–7.
- Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 2019;133:1821–30.
- Thonier V. Immuno-hematological findings in delayed hemolytic transfusion reaction (DHTR). Transfus Clin Biol 2019;26:102–8.
- Floch A. Molecular genetics of the Rh blood group system: alleles and antibodies—a narrative review. Ann Blood 2021;6:29
- Arnoni CP, Vendrame T, Muniz J, Cortez A, Latini F, Castilho L. RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors. Transfusion 2021;61:3473–82.
- Pirenne F, Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood 2018;131:2773–81.
- Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382–92.
- Moller M, Joud M, Storry JR, Olsson ML. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1:240–9.
- Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010;50:13–9.